EMAA's director, Kirsten Moore, publicly defended telehealth protocols for screening ectopic pregnancies, disputing the necessity for ultrasounds and reinforcing the safety and importance of remote medication abortion access amid efforts by anti-abortion groups to restrict mifepristone use.

The article highlights efforts to expand access to telehealth for medication abortion care by addressing and advocating for the removal of regulatory and reimbursement barriers. This effort supports health equity and challenges regressive policies that restrict access, aligning with anti-authoritarian principles by promoting marginalized communities’ rights.

The Expanding Medication Abortion Access Project issued a statement supporting lawsuits that challenge state restrictions on medication abortion. The statement emphasized that such restrictions conflict with FDA-approved safety measures and hinder access to a proven, effective method of ending pregnancy, thereby resisting politically motivated interference in healthcare.

House Democratic leaders introduced a resolution supporting equitable, science-based medication abortion policies, with endorsement from multiple medical and reproductive rights organizations, including the Expand Medication Abortion Access Project (EMAA). This resolution calls for eliminating medically unnecessary restrictions on mifepristone, thereby enhancing access for marginalized communities.